NASDAQ:IMI - Intermolecular Stock Price, Price Target & More

$1.27 +0.01 (+0.79 %)

(As of 04/19/2018 09:18 AM ET)

Previous Close$1.26

Today's Range$1.25 - $1.34

52-Week Range$0.80 - $1.65

Volume5,000 shs

Average Volume47,047 shs

Market Capitalization$62.50 million

P/E RatioN/A

Dividend YieldN/A

Beta1.08

About Intermolecular (NASDAQ:IMI)

Intermolecular, Inc. engages in the development of advanced materials using high productivity combinatorial (HPC) technology platform for the semiconductors, consumer electronics, automotive, and aerospace industries worldwide. The company's HPC platform includes Tempus processing tools, automated characterization methods, and informatics analysis software for research and development using combinatorial process systems in concert with established chemical vapor deposition, physical vapor deposition, and atomic layer deposition methods. It serves various markets, including semiconductor, glass, advanced alloys, light-emitting diodes, flat-panel displays, and others. The company was formerly known as The BEP Group, Inc. and changed its name to Intermolecular, Inc. in November 2004. Intermolecular, Inc. was founded in 2004 and is headquartered in San Jose, California.

Receive IMI News and Ratings via Email

Sign-up to receive the latest news and ratings for IMI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Semiconductors & related devices

Sub-IndustrySemiconductors

SectorComputer and Technology

SymbolNASDAQ:IMI

CUSIP45882D10

Webwww.intermolecular.com

Phone408-582-5700

Debt

Debt-to-Equity RatioN/A

Current Ratio5.84%

Quick Ratio5.84%

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales$37.20 million

Price / Sales1.69

Cash FlowN/A

Price / CashN/A

Book Value$0.73 per share

Price / Book1.74

Profitability

EPS (Most Recent Fiscal Year)N/A

Net Income$-10,400,000.00

Net Margins-27.96%

Return on Equity-27.94%

Return on Assets-22.35%

Miscellaneous

Employees105

Outstanding Shares49,600,000

How to Become a New Pot Stock Millionaire

Intermolecular (NASDAQ:IMI) Frequently Asked Questions

What is Intermolecular's stock symbol?

Intermolecular trades on the NASDAQ under the ticker symbol "IMI."

How were Intermolecular's earnings last quarter?

Intermolecular Inc (NASDAQ:IMI) posted its quarterly earnings data on Tuesday, February, 13th. The semiconductor company reported $0.01 earnings per share for the quarter, topping the consensus estimate of ($0.02) by $0.03. The semiconductor company earned $10.55 million during the quarter. Intermolecular had a negative net margin of 27.96% and a negative return on equity of 27.94%. View Intermolecular's Earnings History.

When is Intermolecular's next earnings date?

Intermolecular is scheduled to release their next quarterly earnings announcement on Wednesday, May, 2nd 2018. View Earnings Estimates for Intermolecular.

Who are some of Intermolecular's key competitors?

Some companies that are related to Intermolecular include QuickLogic (QUIK), Resonant (RESN), POET Technologies (POETF), ReneSola (SOL), LightPath Technologies (LPTH), On Track Innovations (OTIV), Supercom (SPCB), O2Micro International (OIIM), Yingli (YGE), Rubicon Technology (RBCN), Netlist (NLST), SemiLEDs (LEDS), MoSys (MOSY), LDK Solar (LDKYQ) and TranSwitch (TXCCQ).

Who are Intermolecular's key executives?

Intermolecular's management team includes the folowing people:

Dr. Bruce M. McWilliams Ph.D., Non Exec. Chairman & Consultant (Age 62)
Mr. Christian F. Kramer, Chief Exec. Officer, Pres & Director (Age 56)
Mr. C. Richard Neely Jr., Consultant (Age 64)
Mr. Bill Roeschlein, CFO & Principal Accounting Officer (Age 48)
Mr. Milind Weling, Sr. VP of Programs & Operations

Has Intermolecular been receiving favorable news coverage?

Media coverage about IMI stock has been trending positive this week, Accern reports. Accern identifies negative and positive media coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Intermolecular earned a media sentiment score of 0.30 on Accern's scale. They also assigned media coverage about the semiconductor company an impact score of 44.14 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the next several days.

How do I buy shares of Intermolecular?

Shares of IMI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Intermolecular's stock price today?

One share of IMI stock can currently be purchased for approximately $1.27.

How big of a company is Intermolecular?

Intermolecular has a market capitalization of $62.50 million and generates $37.20 million in revenue each year. Intermolecular employs 105 workers across the globe.

How can I contact Intermolecular?

Intermolecular's mailing address is 3011 NORTH FIRST STREET, SAN JOSE CA, 95134. The semiconductor company can be reached via phone at 408-582-5700 or via email at [email protected]

MarketBeat Community Rating for Intermolecular (IMI)

Community Ranking:		2.0 out of 5 ( )
Outperform Votes:		89 (Vote Outperform)
Underperform Votes:		131 (Vote Underperform)
Total Votes:		220

MarketBeat's community ratings are surveys of what our community members think about Intermolecular and other stocks. Vote "Outperform" if you believe IMI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IMI will underperform the S&P 500 over the long term. You may vote once every thirty days.

Intermolecular (NASDAQ:IMI) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	N/A	N/A	Hold	Hold
Consensus Rating Score:	N/A	N/A	2.00	2.00
Ratings Breakdown:	0 Sell Rating(s) 0 Hold Rating(s) 0 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 0 Hold Rating(s) 0 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 1 Hold Rating(s) 0 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 1 Hold Rating(s) 0 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	N/A	N/A	N/A	N/A
Price Target Upside:	N/A	N/A	N/A	N/A

Intermolecular (NASDAQ:IMI) Consensus Price Target History

Price Target History for Intermolecular (NASDAQ:IMI)

Intermolecular (NASDAQ:IMI) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price	Details
2/16/2017	Needham & Company LLC	Reiterated Rating	Hold		N/A

(Data available from 4/19/2016 forward)

Intermolecular (NASDAQ:IMI) Earnings History and Estimates Chart

Earnings by Quarter for Intermolecular (NASDAQ:IMI)

Intermolecular (NASDAQ IMI) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
5/2/2018		($0.03)					N/A
2/13/2018	Q4 2017	($0.02)	$0.01		$10.55 million	View	Listen
11/2/2017	Q3 2017		($0.04)		$8.62 million	View	N/A
8/8/2017	Q2 2017		($0.06)		$8.09 million	View	N/A
5/4/2017	Q1 2017		($0.12)		$9.95 million	View	N/A
2/9/2017	Q416	($0.08)	($0.05)	$10.20 million	$10.50 million	View	Listen
11/2/2016	Q3 2016	($0.13)	($0.14)		$10.57 million	View	N/A
8/4/2016	Q2 2016		($0.08)		$10.05 million	View	N/A
5/5/2016	Q1 2016	($0.09)	($0.03)	$14.00 million	$14.52 million	View	N/A
2/4/2016	Q4 2015	($0.11)	($0.04)	$12.55 million	$13.46 million	View	N/A
11/5/2015	Q3 2015	($0.12)	($0.12)	$11.20 million	$11.53 million	View	N/A
8/6/2015	Q2 2015		($0.12)	$10.50 million	$10.99 million	View	N/A
5/7/2015	Q1 2015	($0.16)	($0.15)	$9.60 million	$9.85 million	View	N/A
2/12/2015	Q414	($0.10)	($0.10)	$10.40 million	$11.00 million	View	N/A
10/31/2014	Q314	($0.09)	($0.07)	$10.60 million	$10.90 million	View	N/A
8/1/2014	Q2 2014	($0.19)	($0.14)	$9.00 million	$9.93 million	View	N/A
5/6/2014	Q1	($0.05)	($0.06)	$15.51 million	$15.91 million	View	N/A
2/6/2014		($0.07)	($0.07)	$15.57 million	$15.60 million	View	N/A
2/6/2014		($0.07)	($0.07)	$15.57 million	$15.60 million	View	N/A
2/6/2014	Q413	($0.07)	($0.07)	$15.57 million	$15.60 million	View	N/A
10/24/2013	Q313	($0.03)	($0.05)	$15.50 million	$17.70 million	View	N/A
7/25/2013	Q213	($0.01)	$0.01	$16.54 million	$16.60 million	View	N/A
4/25/2013	Q1 2013		$0.03	$16.97 million	$17.43 million	View	N/A
2/7/2013	Q4 2013	$0.01	$0.03	$16.68 million	$17.40 million	View	N/A
10/25/2012		($0.03)	$0.02			View	N/A
7/26/2012		($0.03)	($0.02)			View	N/A
2/7/2012	Q4 2011	($0.04)	($0.02)			View	N/A

(Earnings results data provided by Zacks Investment Research)

Intermolecular (NASDAQ:IMI) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date

(Data available from 1/1/2013 forward)

Intermolecular (NASDAQ IMI) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 45.40%
Institutional Ownership Percentage: 37.32%

Insider Trading History for Intermolecular (NASDAQ:IMI)

Institutional Ownership by Quarter for Intermolecular (NASDAQ:IMI)

Intermolecular (NASDAQ IMI) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/7/2017	Lloyd I Miller III	Major Shareholder	Buy	600	$0.86	$516.00	70,368
9/5/2017	Lloyd I Miller III	Major Shareholder	Buy	1,909	$0.86	$1,641.74	70,368
9/1/2017	Lloyd I Miller III	Major Shareholder	Buy	34,109	$0.86	$29,333.74	70,368
8/31/2017	Lloyd I Miller III	Major Shareholder	Buy	1,612	$0.86	$1,386.32	70,368
8/28/2017	Lloyd I Miller III	Major Shareholder	Buy	400	$0.86	$344.00	70,368
8/21/2017	Lloyd I Miller III	Major Shareholder	Buy	300	$0.86	$258.00	70,368
6/22/2017	Lloyd I Miller III	Major Shareholder	Buy	80,000	$0.88	$70,400.00	70,368
6/20/2017	Lloyd I Miller III	Major Shareholder	Buy	6,659	$0.86	$5,726.74	70,368
5/24/2017	Lloyd I Miller III	Major Shareholder	Buy	107	$0.85	$90.95	70,368
5/23/2017	Lloyd I Miller III	Major Shareholder	Buy	29,020	$0.85	$24,667.00	70,368
5/22/2017	Lloyd I Miller III	Major Shareholder	Buy	5,590	$0.85	$4,751.50	70,368
5/19/2017	Lloyd I Miller III	Major Shareholder	Buy	6,564	$0.85	$5,579.40	70,368
5/18/2017	Lloyd I Miller III	Major Shareholder	Buy	2,132	$0.85	$1,812.20	70,368
5/17/2017	Lloyd I Miller III	Major Shareholder	Buy	12,743	$0.85	$10,831.55	70,368
5/16/2017	Lloyd I Miller III	Major Shareholder	Buy	9,325	$0.85	$7,926.25	70,368
5/15/2017	Lloyd I Miller III	Major Shareholder	Buy	8,817	$0.85	$7,494.45	70,368
5/12/2017	Lloyd I Miller III	Major Shareholder	Buy	4,642	$0.85	$3,945.70	70,368
2/28/2017	Rick Neely	CFO	Sell	1,145	$1.02	$1,167.90	83,601
12/16/2016	William C Martin	Major Shareholder	Buy	214,294	$1.02	$218,579.88
11/18/2016	William C Martin	Major Shareholder	Buy	400	$1.00	$400.00
11/17/2016	William C Martin	Major Shareholder	Buy	990,452	$0.85	$841,884.20
10/14/2016	Rick Neely	CFO	Sell	4,586	$0.95	$4,356.70	82,246
8/15/2016	Irwin Federman	Director	Buy	100,000	$1.25	$125,000.00	376,607
8/12/2016	William C Martin	Major Shareholder	Buy	10,944	$1.25	$13,680.00
8/11/2016	William C Martin	Major Shareholder	Buy	2,165,634	$1.02	$2,208,946.68
5/17/2016	Irwin Federman	Director	Buy	100,000	$1.90	$190,000.00	355,897
3/1/2016	Rick Neely	CFO	Sell	940	$2.18	$2,049.20	86,832
2/24/2016	Irwin Federman	Director	Buy	5,900	$2.12	$12,508.00	255,897
2/16/2016	Irwin Federman	Director	Buy	4,716	$2.12	$9,997.92	249,997
2/11/2016	Irwin Federman	Director	Buy	17,878	$2.10	$37,543.80	245,281
12/9/2015	Irwin Federman	Director	Buy	5,603	$2.05	$11,486.15	227,403
12/8/2015	Irwin Federman	Director	Buy	1,600	$2.04	$3,264.00	227,403
12/7/2015	Irwin Federman	Director	Buy	200	$2.05	$410.00	227,403
11/17/2015	Irwin Federman	Director	Buy	4,600	$2.03	$9,338.00	218,900
11/16/2015	Irwin Federman	Director	Buy	64,300	$2.00	$128,600.00	214,300
10/5/2015	Rick Neely	CFO	Sell	3,807	$1.86	$7,081.02	98,902
9/23/2015	William C Martin	Major Shareholder	Buy	283,913	$1.75	$496,847.75
6/25/2015	Rick Neely	CFO	Sell	33,407	$1.95	$65,143.65
11/13/2014	Irwin Federman	Director	Buy	50,000	$2.14	$107,000.00
11/4/2014	Irwin Federman	Director	Buy	100,000	$2.25	$225,000.00
10/3/2014	Rick Neely	CFO	Sell	3,884	$2.31	$8,972.04
7/29/2014	Hector Thomas Blanco	VP	Sell	3,032	$2.24	$6,791.68
7/23/2014	Hector Thomas Blanco	VP	Sell	1,968	$2.20	$4,329.60
5/1/2014	Sandeep Jaggi	SVP	Sell	5,569	$2.70	$15,036.30	98,617
3/31/2014	Raj Jammy	SVP	Sell	5,356	$2.76	$14,782.56	59,644
3/3/2014	Tony Chiang	CTO	Sell	1,476	$2.64	$3,896.64	278,797
2/6/2014	David Lazovsky	CEO	Sell	4,552	$4.02	$18,299.04	2,745,638
1/28/2014	Sandeep Jaggi	SVP	Sell	2,322	$4.06	$9,427.32	77,978
1/28/2014	Sandeep Nijhawan	VP	Sell	4,064	$4.06	$16,499.84	106,086
1/28/2014	Tony Chiang	CTO	Sell	1,742	$4.06	$7,072.52	260,273
12/10/2013	David Lazovsky	CEO	Sell	38,500	$5.33	$205,205.00	2,750,190
12/4/2013	Tony Chiang	CTO	Sell	30,000	$5.52	$165,600.00	76,775
11/8/2013	David Lazovsky	CEO	Sell	38,500	$5.58	$214,830.00	2,788,690
10/8/2013	David Lazovsky	CEO	Sell	38,500	$5.80	$223,300.00	2,827,190
9/9/2013	David E Lazovsky	CEO	Sell	38,500	$5.89	$226,765.00
9/5/2013	Tony Chiang	CTO	Sell	39,003	$5.97	$232,847.91	76,775
8/7/2013	David Lazovsky	CEO	Sell	38,500	$6.20	$238,700.00	2,904,190
8/1/2013	Tony P Chiang	CTO	Sell	48,000	$6.31	$302,880.00
7/16/2013	Peter L Eidelman	CFO	Sell	21,753	$6.96	$151,400.88
7/8/2013	David E Lazovsky	CEO	Sell	38,500	$7.34	$282,590.00
7/3/2013	Tony P Chiang	CTO	Sell	78,000	$7.23	$563,940.00
6/17/2013	Peter L Eidelman	CFO	Sell	6,500	$7.30	$47,450.00
6/7/2013	David E Lazovsky	CEO	Sell	38,500	$8.22	$316,470.00
6/3/2013	James Craig Hunter	SVP	Sell	3,500	$8.43	$29,505.00
5/23/2013	Tony P Chiang	CTO	Sell	52,926	$8.40	$444,578.40
5/16/2013	Peter L Eidelman	CFO	Sell	6,500	$8.68	$56,420.00
3/25/2013	Tony P Chiang	CTO	Sell	25,000	$9.53	$238,250.00
2/26/2013	Tony P Chiang	CTO	Sell	72,612	$9.55	$693,444.60
2/21/2013	Bruce M Mcwilliams	Director	Sell	2,132	$9.64	$20,552.48
1/17/2013	Bruce M Mcwilliams	Director	Sell	21,200	$9.27	$196,524.00
12/3/2012	John R Behnke	SVP	Sell	2,500	$6.99	$17,475.00
10/8/2012	David E Lazovsky	CEO	Sell	26,810	$7.23	$193,836.30
9/5/2012	James Craig Hunter	SVP	Sell	3,500	$7.20	$25,200.00
8/23/2012	Tony P Chiang	CTO	Sell	14,266	$7.15	$102,001.90

(Data available from 1/1/2013 forward)

Intermolecular (NASDAQ IMI) News Headlines

Source:

Date	Headline
	Intermolecular to Present at The MicroCap Conference on April 10, 2018 finance.yahoo.com - March 28 at 10:31 AM
	Financial Review: Intermolecular (IMI) vs. Itron (ITRI) www.americanbankingnews.com - March 27 at 1:28 AM
	Edited Transcript of IMI earnings conference call or presentation 13-Feb-18 10:00pm GMT finance.yahoo.com - March 18 at 10:16 AM
	Texas Instruments (TXN) and Intermolecular (IMI) Critical Review www.americanbankingnews.com - March 10 at 3:22 PM
	Silicon Image (SIMG) & Intermolecular (IMI) Head-To-Head Contrast www.americanbankingnews.com - February 24 at 9:12 PM
	Intermolecular (IMI) Announces Quarterly Earnings Results, Beats Expectations By $0.03 EPS www.americanbankingnews.com - February 14 at 12:26 PM
	Intermolecular posts 4Q profit finance.yahoo.com - February 14 at 8:38 AM
	Intermolecular Reports Fourth Quarter and Full Year 2017 Financial Results finance.yahoo.com - February 13 at 5:02 PM
	Intermolecular (IMI) to Release Quarterly Earnings on Wednesday www.americanbankingnews.com - January 31 at 2:28 AM
	BRIEF-Intermolecular, Sitri Expand Strategic Alliance www.reuters.com - January 23 at 4:42 PM
	Intermolecular and SITRI Expand Strategic Alliance to Accelerate Development of Advanced Memory Technologies for the China Market www.prnewswire.com - January 22 at 7:25 PM
	Intermolecular Sets Fiscal Fourth Quarter and Full Year 2017 Earnings Call for Tuesday, February 13, 2018 at 5 p.m. ET finance.yahoo.com - January 17 at 10:49 AM
	Intermolecular To Present At 20th Annual Needham Growth Conference finance.yahoo.com - January 4 at 10:47 AM
	Intermolecular (IMI) Raised to Hold at ValuEngine www.americanbankingnews.com - January 1 at 8:14 PM
	Head-To-Head Analysis: CEVA (CEVA) and Intermolecular (IMI) www.americanbankingnews.com - December 28 at 5:04 PM
	ETFs with exposure to Intermolecular, Inc. : December 28, 2017 finance.yahoo.com - December 28 at 1:50 PM
	ETFs with exposure to Intermolecular, Inc. : November 21, 2017 finance.yahoo.com - November 21 at 8:02 PM
	Intermolecular and SITRI Form Strategic Alliance to Accelerate Materials Innovation - "More than Moore" finance.yahoo.com - November 20 at 8:15 PM
	Intermolecular To Participate In The Sixth Annual NYC Investor Summit 2017 finance.yahoo.com - November 17 at 6:32 AM
	Intermolecular, Inc. :IMI-US: Earnings Analysis: Q3, 2017 By the Numbers : November 9, 2017 finance.yahoo.com - November 11 at 11:54 AM
	ETFs with exposure to Intermolecular, Inc. : November 10, 2017 finance.yahoo.com - November 11 at 11:54 AM
	Edited Transcript of IMI earnings conference call or presentation 2-Nov-17 9:00pm GMT finance.yahoo.com - November 5 at 7:22 PM
	Intermolecular's (IMI) CEO Chris Kramer on Q3 2017 Results - Earnings Call Transcript seekingalpha.com - November 4 at 2:13 AM
	Intermolecular Announces Third Quarter 2017 Financial Results www.bizjournals.com - November 3 at 9:46 AM
	Intermolecular, Inc. (IMI) Set to Announce Quarterly Earnings on Thursday www.americanbankingnews.com - October 26 at 5:51 AM
	Intermolecular To Report Third Quarter Fiscal 2017 Financial Results on November 2, 2017 finance.yahoo.com - October 18 at 1:14 AM
	Applied Micro Circuits (AMCC) & Intermolecular (IMI) Head-To-Head Analysis www.americanbankingnews.com - October 17 at 12:56 PM
	ETFs with exposure to Intermolecular, Inc. : October 10, 2017 finance.yahoo.com - October 10 at 7:14 PM
	Intermolecular (IMI) versus Coherent (COHR) Head-To-Head Review www.americanbankingnews.com - October 8 at 8:08 PM
	Intermolecular (IMI) and The Competition Head-To-Head Review www.americanbankingnews.com - September 28 at 2:28 PM
	What Does Intermolecular Inc’s (IMI) Share Price Indicate? finance.yahoo.com - September 15 at 12:47 AM
	Intermolecular, Inc. (IMI) Major Shareholder Lloyd I. Miller III Buys 34,109 Shares www.americanbankingnews.com - September 5 at 1:38 PM
	ETFs with exposure to Intermolecular, Inc. : August 31, 2017 finance.yahoo.com - August 31 at 7:49 PM
	Intermolecular, Inc. :IMI-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017 finance.yahoo.com - August 26 at 6:13 AM
	Intermolecular to Present at the 6th Annual Liolios Gateway Conference on September 6, 2017 finance.yahoo.com - August 25 at 7:05 AM
	Intermolecular (IMI) versus Exar (EXAR) Head-To-Head Survey www.americanbankingnews.com - August 18 at 12:22 AM
	Edited Transcript of IMI earnings conference call or presentation 8-Aug-17 9:00pm GMT finance.yahoo.com - August 9 at 5:34 AM
	Intermolecular Announces Second Quarter 2017 Financial Results finance.yahoo.com - August 8 at 7:30 PM
	Intermolecular's High-Throughput Experimentation Platform Speeds Discovery of Next-Generation Non-Volatile Memories finance.yahoo.com - August 1 at 3:25 PM
	Intermolecular To Report Second Quarter Fiscal 2017 Financial Results on August 8, 2017 finance.yahoo.com - July 14 at 3:50 AM
	Intermolecular reports 1Q loss marketbeat.com - May 4 at 7:57 PM
	Intermolecular Announces Restructuring Initiative and Changes in its Leadership Team us.rd.yahoo.com - March 29 at 6:25 PM
	4:18 pm Intermolecular appoints Bill Roeschlein, currently VP of Finance and Corporate Controller, as CFO; also announces restructuring initiative that will lower costs by approx. $4 mln in 2017 us.rd.yahoo.com - March 29 at 6:25 PM
	INTERMOLECULAR INC Files SEC form 8-K, Costs Associated with Exit or Disposal Activities, Change in Directors or Prin biz.yahoo.com - March 29 at 6:25 PM
	INTERMOLECULAR INC Files SEC form 10-K, Annual Report biz.yahoo.com - March 3 at 5:53 PM
	Q4 2016 Intermolecular Inc Earnings Release - After Market Close us.rd.yahoo.com - February 10 at 6:39 PM
	INTERMOLECULAR INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi us.rd.yahoo.com - February 10 at 6:39 PM
	Intermolecular Announces Fourth Quarter 2016 and Full Year 2016 Financial Results www.bizjournals.com - February 9 at 6:49 PM
	INTERMOLECULAR INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits biz.yahoo.com - November 16 at 5:52 PM
	Intermolecular Announces Third Quarter 2016 Financial Results www.prnewswire.com - November 2 at 5:50 PM

Intermolecular (NASDAQ:IMI) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

Intermolecular (NASDAQ:IMI) Income Statement, Balance Sheet and Cash Flow Statement

Intermolecular (NASDAQ IMI) Stock Chart for Thursday, April, 19, 2018

Loading chart…

This page was last updated on 4/19/2018 by MarketBeat.com Staff